The Alternative Activation Pathway and Complement Component C3 Are Critical for a Protective Immune Response against Pseudomonas aeruginosa in a Murine Model of Pneumonia

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2899-2906

  Mueller Ortiz, Stacey L ^a   Drouin, Scott M ^a   Wetsel, Rick A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNITY; IN VITRO STUDY; LEUKOCYTE ADHERENCE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTE; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; SURVIVAL RATE;

ANIMALS; BACTERIAL ADHESION; BLOOD BACTERICIDAL ACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; CYTOKINES; FEMALE; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OPSONIN PROTEINS; PHAGOCYTOSIS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 2142761564     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2899-2906.2004     Document Type: Article

References (44)

1. Bjornson, A. B., and J. G. Michael. 1974. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium. J. Infect. Dis. 130(Suppl.):S119-S126.
2. Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148:1280-1285.
3. Cerquetti, M. C., D. O. Sordelli, J. A. Bellanti, and A. M. Hooke. 1986. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect. Immun. 52:853-857.
4. Circolo, A., G. Garnier, W. Fukuda, X. Wang, T. Hidvegi, A. J. Szalai, D. E. Briles, J. E. Volanakis, R. A. Wetsel, and H. R. Colten. 1999. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42:135-149.
5. Davies, J., O. Neth, E. Alton, N. Klein, and M. Turner. 2000. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet 355:1885-1886.
6. Driscoll, K. E. 1994. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 20:473-490.
7. Ehlers, M. R. 2000. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2:289-294.
8. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, E. Kremmer, F. S. Rosen, and M. C. Carroll. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549-556.
9. Frank, D. W., A. Vallis, J. P. Wiener-Kronish, A. Roy-Burman, E. G. Spack, B. P. Mullaney, M. Megdoud, J. D. Marks, R. Fritz, and T. Sawa. 2002. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J. Infect. Dis. 186:64-73.
10. Gross, G. N., S. R. Rehm, and A. K. Pierce. 1978. The effect of complement depletion on lung clearance of bacteria. J. Clin. Investig. 62:373-378.
11. Gu, L., B. Rutledge, J. Fiorillo, C. Ernst, I. Grewal, R. Flavell, R. Gladue, and B. Rollins. 1997. In vivo properties of monocyte chemoattractant protein-1. J. Leukoc. Biol. 62:577-580.
12. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford. 2000. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165:1513-1519.
13. Heidbrink, P. J., G. B. Toews, G. N. Gross, and A. K. Pierce. 1982. Mechanisms of complement-mediated clearance of bacteria from the murine lung. Am. Rev. Respir. Dis. 125:517-520.
14. Hemachandra, S., K. Kamboj, J. Copfer, G. Pier, L. L. Green, and J. R. Schreiber. 2001. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal Pseudomonas sepsis. Infect. Immun. 69:2223-2229.
15. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
16. Hopken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383:86-89.
17. Janeway, C. A., P. Travers, M. Walport, and M. Shlomchick. 2001. Innate immunity, immunobiology, 5th ed. Garland Publishing, New York, N.Y.
18. Kohl, J. 2001. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Mol. Immunol. 38:175-187.
19. Larsen, G. L., B. C. Mitchell, T. B. Harper, and P. M. Henson. 1982. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 126:306-311.
20. Lee, J., G. Cacalano, T. Camerato, K. Toy, M. W. Moore, and W. I. Wood. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155:2158-2164.
21. LeVine, A. M., K. E. Kurak M. D. Bruno, J. M. Stark J. A. Whitsett, and T. R. Korfhagen. 1998. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am. J. Respir. Cell. Mol. Biol. 19:700-708.
22. Liu, P. V. 1966. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. III. Identity of the lethal toxins produced in vitro and in vivo. J. Infect. Dis. 116:481-489.
23. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
24. Matsumoto, M., W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fujita, T. Hidvegi, D. D. Chaplin, and H. R. Colten. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94:8720-8725.
25. Muller-Eberhard, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321-347.
26. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:688-693.
27. Peterson, P. K., Y. Kim, D. Schmeling, M. Lindemann, J. Verhoef, and P. G. Quie. 1978. Complement-mediated phagocytosis of Pseudomonas aeruginosa. J. Lab. Clin. Med. 92:883-894.
28. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157:5016-5021.
29. Rehm, S. R., G. N. Gross, and A. K. Pierce. 1980. Early bacterial clearance from murine lungs. Species-dependent phagocyte response. J. Clin. Investig. 66:194-199.
30. Rice, A. R., M. A. Hamilton, and A. K. Camper. 2000. Apparent surface associated lag time in growth of primary biofilm cells. Microb. Ecol. 40:8-15.
31. Sengelov, H. 1995. Complement receptors in neutrophils. Crit. Rev. Immunol. 15:107-131.
32. Shime, N., T. Sawa, J. Fujimoto, K. Faure, L. R. Allmond, T. Karaca, B. L. Swanson, E. G. Spack, and J. P. Wiener-Kronish. 2001. Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa. J. Immunol. 167:5880-5886.
33. Skerrett, S. J., T. R. Martin, E. Y. Chi, J. J. Peschon, K. M. Mohler, and C. B. Wilson. 1999. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am. J. Physiol. 276:L715-L727.
34. Sordelli, D. O., M. C. Cerquetti, A. Morris Hooke, and J. A. Bellanti. 1985. Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect. Immun. 49:265-269.
35. Strieter, R. M., S. L. Kunkel, M. P. Keane, and T. J. Standiford. 1999. Chemokines in lung injury: Thomas A. Neff lecture. Chest 116:103S-110S.
36. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68:4289-4296.
37. Van Damme, J., A. Wuyts, G. Froyen, E. Van Coillie, S. Struyf, A. Billiau, P. Proost, J. M. Wang, and G. Opdenakker. 1997. Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J. Leukoc. Biol. 62:563-569.
38. van Heeckeren, A. M., J. Tscheikuna, R. W. Walenga, M. W. Konstan, P. B. Davis, B. Erokwu, M. A. Haxhiu, and T. W. Ferkol. 2000. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am. J. Respir. Crit. Care Med. 161:271-279.
39. Ward, P. A., I. H. Lepow, and L. J. Newman. 1968. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am. J. Pathol. 52:725-736.
40. Werfel, T., M. Oppermann, M. Schulze, G. Krieger, M. Weber, and O. Gotze. 1992. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 79:152-160.
41. Wetsel, R. A., J. Kildsgaard, and D. L. Haviland. 2000. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation, p. 113. In J. D. Lambris and V. M. Holers (ed.), Contemporary immunology: therapeutic interventions in the complement system. Humana Press, Totowa, N.J.
42. Yancey, K. B., J. O'Shea, T. Chused, E. Brown, T. Takahashi, M. M. Frank, and T. J. Lawley. 1985. Human C5a modulates monocyte Fc and C3 receptor expression. J. Immunol. 135:465-470.
43. Young, L. S., and D. Armstrong. 1972. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J. Infect. Dis. 126:257-276.
44. Yu, H., S. Z. Nasr, and V. Deretic. 2000. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 68:2142-2147.